Elevation Oncology, Inc.
Elevation Oncology, Inc. (ELEV) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
elev · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Elevation Oncology, Inc. (ELEV) measures how much investors pay for each dollar of the company's trailing earnings. ELEV's current PE ratio of N/A is calculated by dividing its stock price of $0.36 by its TTM earnings per share of -$0.42.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2019 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Elevation Oncology, Inc.You ELEV | $22M | N/A | — | -$0.42 |
 AnPac Bio-Medical Science Co., Ltd. ANPC | $27M | N/A | — | -$54.18 |
 Dominari Holdings Inc. DOMH | $51M | N/A | — | -$1.57 |
 Kineta, Inc. KA | $7M | N/A | — | -$1.42 |
 LakeShore Biopharma Co., Ltd LSB | $26M | N/A | — | -$0.94 |
 MEI Pharma, Inc. MEIP | $20M | N/A | — | -$2.39 |
 MetaVia Inc. MTVA | $5M | N/A | — | -$7.35 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-0.78 | — | |
2023-12-31 FY2023 | — | $-1.34 | — | |
2022-12-31 FY2022 | — | $-4.09 | — | |
2021-12-31 FY2021 | — | $-1.38 | — | |
2020-12-31 FY2020 | — | $-0.73 | — | |
2019-12-31 FY2019 | — | $-0.25 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Elevation Oncology, Inc. (ELEV) measures how much investors pay for each dollar of the company's trailing earnings. ELEV's current PE ratio of N/A is calculated by dividing its stock price of $0.36 by its TTM earnings per share of -$0.42.
Frequently asked questions
ELEV pe ratio · 6 questionsELEV's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.36 and TTM EPS of -$0.42. Data sourced from Financial Modeling Prep via ELEV's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Elevation Oncology, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09